Mylan Laboratories Limited Atorvastatin Export Data — India (DGFT 2022–2026)

Name: Mylan Laboratories Limited Atorvastatin Export Records India — #3 Exporter, 330 Shipments, $16.5M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-05-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Atorvastatin

India Pharmaceutical Trade Intelligence

$1.1B477 Suppliers145 CountriesHS 30049099

ExportsIndia → UNITED STATES52.5%India → CANADA25.9%

ImportsCROATIA → India$3.5M CANADA → India$2.5M

#1 Supplier: INTAS PHARMACEUTICALS #1 Buyer: APOTEX CORP

Mylan Laboratories Limited — Atorvastatin Exporter #3 | $16.5M Trade Value | TransData Nexus | TransData Nexus

Mylan Laboratories Limited — Atorvastatin Exporter Profile

Indian Pharmaceutical Exporter · #3 for Atorvastatin · $16.5M export value · DGFT Verified

Mylan Laboratories Limited is the #3 Indian exporter of Atorvastatin with $16.5M in export value and 330 verified shipments. Mylan Laboratories Limited holds a 1.5% market share in Atorvastatin exports across 7 countries. The company exports 91 pharmaceutical products worth $634.8M across 26 therapeutic categories.

Mylan Laboratories Limited — Atorvastatin Export Profile: Buyers & Destinations

Mylan Laboratories Limited Atorvastatin export treemap — buyers and destination countries | TransData Nexus

Where Does Mylan Laboratories Limited Export Atorvastatin?

Country	Value	Shipments	Share
UNITED STATES	$13.9M	316	82.1%
CANADA	$1.8M	43	10.6%
NETHERLANDS	$503.6K	14	3.0%
FRANCE	$486.2K	12	2.9%
ITALY

Who Are the Top Buyers of Atorvastatin from Mylan Laboratories Limited?

Buyer	Country	Value	Orders
MYLAN PHARMACEUTICALS INC	UNITED STATES	$5.9M	142
MYLAN PHARMACEUTICALS INC,	UNITED STATES	$4.9M	112
M/S. MYLAN PHARMACEUTICALS INC,	UNITED STATES	$1.4M	28
XXLANXXRELXXD LXXITEXX NEXXNHAXXCOUXX MXXAHIXX RO	FRANCE	$1.2M	31
MYLAN PHARMACEUTICALS INC.,	UNITED STATES	$1.0M	21
MYLAN PHARMACEUTICALS ULC	CANADA	$876.2K	21
MYLAN PHARMACEUTICALS ULC,	CANADA	$821.2K	20
MYLANPHARMACEUTICALS INC	UNITED STATES	$500.0K	10
M/S. MYLAN PHARMACEUTICALS ULC	CANADA	$100.0K	2
MYLAN PHARMACEUTICALS INC,.	UNITED STATES	$100.0K	2

Mylan Laboratories Limited supplies Atorvastatin to 12 buyers globally. The largest buyer is MYLAN PHARMACEUTICALS INC (UNITED STATES), followed by MYLAN PHARMACEUTICALS INC, (UNITED STATES) and M/S. MYLAN PHARMACEUTICALS INC, (UNITED STATES). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.

What Atorvastatin Formulations Does Mylan Laboratories Limited Export?

Product Description / Formulation	Value	Shipments
ATORVASTATIN CALCIUM TABLETS USP 80 MG 5	$1.0M	20
ATORVASTATIN CALCIUM TABLETS USP 40 MG 5	$800.0K	16
ATORVASTATIN CALCIUM TABLETS USP 40 MG 9	$550.0K	11
ATORVASTATIN CALCIUM TABLETS USP 80 MG 9	$400.0K	8
ATORVASTATIN CALCIUM TABLETS USP 20 MG 9	$350.0K	7
AMLODIPINE AND ATORVASTATIN TABLETS USP	$334.1K	17
ATORVASTATIN CALCIUM TABLETS USP 10 MG 9	$321.1K	7
ATORVASTATIN CALCIUM TABLETS USP 10 MG 5	$317.9K	7
ATORVASTATIN CALCIUM TABLETS USP 20 MG 5	$250.0K	5
ATORVASTATIN CALCIUM TABLETS USP 80MG 500BT TAB PACKS 10888	$200.0K	4

Mylan Laboratories Limited exports 212 distinct Atorvastatin formulations including tablets, capsules, syrups, and combination drugs. The top formulation is ATORVASTATIN CALCIUM TABLETS USP 80 MG 5 with 20 shipments worth $1.0M. Notable combination products include fixed-dose combinations with other active ingredients, meeting diverse global regulatory requirements.

How Does Mylan Laboratories Limited Compare to Nearest Atorvastatin Exporters?

Exporters ranked immediately above and below #3 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
9	GRAVITI PHARMACEUTICALS PRIVATE LIMITED	$24.0M	664	1	$36.1K
2	PIRAMAL PHARMA LIMITED	$21.4M	429	1	$50.0K
3	MYLAN LABORATORIES LIMITED ★	$16.5M	330	7	$50.0K
1	INTAS PHARMACEUTICALS LIMITED	$16.4M	328	10	$50.0K
10	MEDREICH LIMITED	$14.6M	291	6	$50.0K

Mylan Laboratories Limited ranks #3 among 477 Indian Atorvastatin exporters. Average shipment value of $50.0K compared to the market average of $657.7K. The closest competitors by value are GRAVITI PHARMACEUTICALS PRIVATE LIMITED and PIRAMAL PHARMA LIMITED.

Which Indian Ports Ship Atorvastatin Exports?

Port	Shipments	% Share
HYDERABAD ICD	2,042	13.6%
HYDERABAD ICD (INSNF6)	1,131	7.5%
NHAVA SHEVA SEA (INNSA1)	842	5.6%
SAHAR AIR	839	5.6%
JNPT/ NHAVA SHEVA SEA	779	5.2%
DELHI AIR	613	4.1%
SAHAR AIR CARGO ACC (INBOM4)	581	3.9%
HYDERABAD AIR	554	3.7%

Geopolitical & Trade Policy Impact on Mylan Laboratories Limited's Atorvastatin Exports

Mylan's export operations are influenced by a complex geopolitical landscape. The Israel-Iran tensions have led to disruptions in Red Sea shipping routes, resulting in increased freight costs and extended transit times. Major shipping lines have implemented 'Emergency Risk Surcharges' ranging from $250 to $500 per TEU, directly impacting the cost structure for Indian pharmaceutical exporters like Mylan. Additionally, diversions around the Cape of Good Hope have further elongated delivery schedules, posing challenges to time-sensitive pharmaceutical shipments.

In the United States, the imposition of tariffs on pharmaceutical imports has prompted Indian companies to reassess their market strategies. While generics have largely remained exempt, the potential for future tariff expansions necessitates vigilance. Mylan, along with other Indian exporters, is exploring market diversification to mitigate reliance on the U.S. market. The recent India-European Union Free Trade Agreement (FTA), signed in January 2026, offers a strategic avenue for expansion. The FTA eliminates tariffs on approximately 97% of EU tariff lines, including pharmaceuticals, thereby enhancing market access for Indian exporters. This agreement is expected to significantly boost India's pharmaceutical exports to Europe, providing a counterbalance to uncertainties in the U.S. market.

Mylan Laboratories Limited — Regulatory Compliance & Quality Standards

Compliance with international regulatory standards remains paramount for Mylan. The FDA's warning letter and import alert in December 2024 concerning the Indore facility underscore the critical importance of stringent quality control measures. The cited violations, including subpar quality control and improper management of manufacturing defects, have necessitated comprehensive corrective actions. Mylan's proactive response aims to restore compliance and reinforce its commitment to quality assurance.

The evolving regulatory environment, particularly in the European Union, further emphasizes the need for adherence to Good Manufacturing Practices (GMP). The EU's Falsified Medicines Directive mandates rigorous compliance to ensure product integrity and patient safety. For Mylan, aligning with these standards is essential to maintain and expand its foothold in the European market.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Atorvastatin shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Mylan Laboratories Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
4.Verified Records: This page is backed by 391 individual customs records matching Mylan Laboratories Limited exporting Atorvastatin, covering 212 formulations to 7 countries via 12 buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 145+ countries, 1,291+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Atorvastatin

Atorvastatin

Mylan Laboratories Limited — Atorvastatin Exporter Profile

Mylan Laboratories Limited — Atorvastatin Export Profile: Buyers & Destinations

Where Does Mylan Laboratories Limited Export Atorvastatin?

Who Are the Top Buyers of Atorvastatin from Mylan Laboratories Limited?

What Is India's Total Atorvastatin Export Value and How Much Does Mylan Laboratories Limited Contribute?

What Is the Average Shipment Value for Mylan Laboratories Limited's Atorvastatin Exports?

How Does Mylan Laboratories Limited Compare to Other Indian Atorvastatin Exporters?

What Atorvastatin Formulations Does Mylan Laboratories Limited Export?

Regulatory Requirements: Exporting Atorvastatin to Key Markets

United States — FDA

Canada — HC

How Does Mylan Laboratories Limited Compare to Nearest Atorvastatin Exporters?

Which Indian Ports Ship Atorvastatin Exports?

What Other Cardiovascular Products Does Mylan Laboratories Limited Export?

Atorvastatin — Export Intelligence Video

Geopolitical & Trade Policy Impact on Mylan Laboratories Limited's Atorvastatin Exports

Mylan Laboratories Limited — Regulatory Compliance & Quality Standards

About Mylan Laboratories Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Atorvastatin Export Data from Mylan Laboratories Limited

Atorvastatin Stats

Company Overview

Top Products by Mylan Laboratories Limited

Related Analysis

Need Detailed Export Data?

Data Source